News

BioMarin: Less Likely M&A Target As New Rival For Best-Selling Drug Emerges (Rating Downgrade)

BioMarin downgraded to Hold amid rising competition, pipeline concerns, and ambitious growth targets, despite solid Q1 2025 ...

Servicenow targets $15B-plus subscription revenue for 2026 as AI momentum drives 21.5% growth

Discover ServiceNow's stellar Q2 2025 results with 21.5% subscription revenue growth, expanded AI adoption, and a raised outlook.

SEI Investments signals strategic expansion through Stratos investment and forecasts stable margins

Gain insights into SEI Investments' Q2 2025 results, including the Stratos acquisition, Board appointments, and strategic growth investments.